Standout Papers

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after fa... 2012 2026 2016 2021 760
  1. Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial (2012)
    Vincent A. Miller, Vera Hirsh et al. The Lancet Oncology

Immediate Impact

9 by Nobel laureates 29 from Science/Nature 59 standout
Sub-graph 1 of 20

Citing Papers

Engineered skin bacteria induce antitumor T cell responses against melanoma
2023 StandoutScience
CAR T therapy beyond cancer: the evolution of a living drug
2023 StandoutNature
20 intermediate papers

Works of Robert M. Lorence being referenced

A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization
2006
Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers
2002
and 8 more

Author Peers

Author Last Decade Papers Cites
Robert M. Lorence 1646 1480 1332 50 3.6k
Clifford P. Stanners 1501 3405 322 97 5.8k
Pradip Roy‐Burman 1258 3389 1567 124 6.0k
J Závada 470 2411 591 67 3.7k
Dominik Mumberg 1453 4181 768 131 6.4k
Roberto Weinmann 1166 4340 277 77 6.2k
Allen Oliff 2558 4100 365 106 6.7k
David Maag 1253 2705 311 57 4.5k
James Barsoum 786 2862 265 63 4.1k
Timothy Kottke 2734 2916 193 83 5.5k
Kimberly R. Kalli 2012 2125 380 100 5.3k

All Works

Loading papers...

Rankless by CCL
2026